MedPath
NMPA Approval

富马酸替诺福韦二吡呋酯

国药准字H20173134

November 25, 2022

国药准字H20173134/Y20190006666

Drug Information

富马酸替诺福韦二吡呋酯

原料药

化学药品

November 25, 2022

Company Information

Applicant Company

海南省定安县塔岭工业区塔中路

Manufacturing Company

海南省定安塔岭工业区塔中路

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

富马酸替诺福韦二吡呋酯 - NMPA 批准文号 | MedPath